histoplasmosis
Information
- Disease name
- histoplasmosis
- Disease ID
- DOID:1731
- Description
- "A primary systemic mycosis that results in systemic fungal infection, has_material_basis_in Histoplasma capsulatum var capsulatum or has_material_basis_in Histoplasma capsulatum var duboisii, transmitted_by airborne spores and has_symptom nonproductive cough, has_symptom headache, has_symptom loss of appetite and has_symptom muscle pains." [url:http\://www.cdc.gov/niosh/hi97146.html]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04059770 | Completed | Phase 2 | Randomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients | February 14, 2020 | March 30, 2022 |
| NCT03059992 | Completed | Phase 3 | Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment | April 1, 2017 | August 17, 2023 |
| NCT00000150 | Completed | Phase 3 | Submacular Surgery Trials (SST) | January 1999 | September 2001 |
| NCT00000627 | Completed | N/A | Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome | November 1994 | |
| NCT00000975 | Completed | Phase 2 | A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS | September 1994 | |
| NCT00000992 | Completed | Phase 1 | A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS | June 1992 | |
| NCT00002159 | Completed | Phase 3 | A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis | ||
| NCT00002438 | Completed | N/A | A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients | ||
| NCT00004808 | Completed | Phase 2 | Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis | September 1991 | |
| NCT00004811 | Completed | Phase 1/Phase 2 | Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis | March 1985 | |
| NCT00006316 | Completed | Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs | |||
| NCT00784368 | Completed | Phase 3 | A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection | January 2008 | May 2009 |
| NCT02493738 | Completed | Phase 1 | A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers | July 2015 | October 2015 |
| NCT00000158 | Unknown status | Phase 3 | Macular Photocoagulation Study (MPS) | February 1979 | |
| NCT02911740 | Withdrawn | N/A | Additive Benefit of the Urine LAM Test to Current TB Diagnostics in HIV Positive Adults in Panama City, Panama | November 2017 | August 2018 |
- Disase is a (Disease Ontology)
- DOID:0050292
- Cross Reference ID (Disease Ontology)
- ICD10CM:B39
- Cross Reference ID (Disease Ontology)
- ICD9CM:115
- Cross Reference ID (Disease Ontology)
- MESH:C538362
- Cross Reference ID (Disease Ontology)
- MESH:D006660
- Cross Reference ID (Disease Ontology)
- NCI:C34977
- Cross Reference ID (Disease Ontology)
- NCI:C77201
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:266218008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0019655
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0035288
- ICD10 preferred id (Insert disease from ICD10)
- D0000653
- ICD10 class code (Insert disease from ICD10)
- B39
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006660